A detailed history of Fny Investment Advisers, LLC transactions in Lian Bio stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 13,800 shares of LIAN stock, worth $4,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,800
Holding current value
$4,140
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$0.3 - $4.99 $4,140 - $68,862
13,800 New
13,800 $4,000
Q2 2022

Jul 12, 2022

SELL
$2.15 - $6.01 $1,720 - $4,808
-800 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$2.8 - $6.21 $2,240 - $4,968
800 New
800 $2,000

Others Institutions Holding LIAN

About LianBio


  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.